Proliferation/NN
index/NN
as/IN
a/DT
prognostic/JJ
marker/NN
in/IN
breast/NN
cancer/NN
./.

BACKGROUND/NN
./.
=====
The/DT
proliferative/JJ
activity/NN
of/IN
tumors/NNS
has/VBZ
been/VBN
extensively/RB
investigated/VBN
with/IN
different/JJ
approaches/NNS
,/,
among/IN
which/WDT
the/DT
use/NN
of/IN
the/DT
monoclonal/JJ
antibody/NN
Ki-67/NN
represents/VBZ
an/DT
easy/JJ
and/CC
reliable/JJ
means/NN
of/IN
assessing/VBG
cell/NN
proliferation/NN
./.
=====
In/IN
this/DT
study/NN
,/,
the/DT
proliferative/JJ
activity/NN
of/IN
129/CD
primary/JJ
breast/NN
cancers/NNS
was/VBD
investigated/VBN
,/,
and/CC
the/DT
results/NNS
were/VBD
related/JJ
to/TO
prognosis/NN
./.
=====
METHODS/NNS
./.
=====
Tumor/NN
samples/NNS
,/,
obtained/VBN
from/IN
129/CD
patients/NNS
who/WP
underwent/VBD
surgery/NN
between/IN
January/NNP
1987/CD
and/CC
December/NNP
1988/CD
,/,
were/VBD
processed/VBN
for/IN
staining/VBG
by/IN
an/DT
immunohistochemical/JJ
procedure/NN
(/(
avidin-biotin/NN
complex/NN
)/)
./.
=====
The/DT
median/JJ
time/NN
of/IN
observation/NN
was/VBD
42/CD
months/NNS
(/(
range/NN
,/,
31-55/CD
months/NNS
)/)
./.
=====
Life-table/JJ
analysis/NN
(/(
Mantel-Cox/NN
)/)
was/VBD
used/VBN
to/TO
assess/VB
the/DT
probability/NN
of/IN
disease-free/JJ
survival/NN
(/(
DFS/NN
)/)
and/CC
overall/JJ
survival/NN
(/(
OS/NN
)/)
./.
=====
RESULTS/NNS
./.
=====
Tumors/NNS
with/IN
high/JJ
Ki-67/NN
proliferation/NN
indices/NNS
(/(
>/JJR
20/CD
%/NN
)/)
were/VBD
associated/VBN
with/IN
a/DT
higher/JJR
4-year/JJ
probability/NN
of/IN
relapse/NN
of/IN
disease/NN
(/(
55.3/CD
%/NN
versus/CC
79.1/CD
%/NN
;/:
P/NN
=/JJ
0.003/CD
)/)
and/CC
death/NN
(/(
71/CD
%/NN
versus/CC
95.6/CD
%/NN
;/:
P/NN
=/JJ
0.00005/CD
)/)
when/WRB
compared/VBN
with/IN
tumors/NNS
with/IN
low/JJ
Ki-67/NN
values/NNS
./.
=====
In/IN
addition/NN
,/,
this/DT
proliferative/JJ
parameter/NN
maintained/VBD
its/PRP$
prognostic/JJ
significance/NN
when/WRB
the/DT
patients/NNS
were/VBD
stratified/VBN
according/VBG
to/TO
lymph/NN
node/NN
involvement/NN
,/,
menopausal/JJ
status/NN
,/,
and/CC
nuclear/JJ
estrogen/NN
receptor/NN
content/NN
./.
=====
CONCLUSIONS/NNS
./.
=====
Tumor/NN
proliferative/JJ
activity/NN
as/IN
evaluated/VBN
by/IN
the/DT
monoclonal/JJ
antibody/NN
Ki-67/NN
seems/VBZ
to/TO
be/VB
an/DT
effective/JJ
indicator/NN
of/IN
prognosis/NN
in/IN
breast/NN
cancer/NN
for/IN
DFS/NN
and/CC
OS/NN
./.